| ID | Age | Sex | State | Date โผ | Onset Days | Vaccine | Manufacturer | Lot # | Symptoms | Narrative | ๐ | ๐ฅ | ๐ | โฟ | โ ๏ธ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2839252 | 05/02/2025 |
VARZOS |
UNKNOWN MANUFACTURER |
UNK |
Pain
Pain
|
painful thing I've ever experienced/agony; This non-serious case was reported by a consumer via...
painful thing I've ever experienced/agony; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced pain (Verbatim: painful thing I've ever experienced/agony). The outcome of the pain was resolved (duration 29 days). It was unknown if the reporter considered the pain to be related to Shingles vaccine. It was unknown if the company considered the pain to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 24-APR-2025 The case was received from the patient via interactive digital media. The reporter reported that the most painful thing he/she had ever experienced. Twenty nine days of pure agony because he/she forgot to get the second vaccine..
More
|
|||||||||
| 2839253 | 05/02/2025 |
VARZOS |
UNKNOWN MANUFACTURER |
UNK |
Herpes zoster, Vaccination failure
Herpes zoster, Vaccination failure
|
suspected vaccination failure; shingles; This serious case was reported by a consumer via interactiv...
suspected vaccination failure; shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: shingles). The patient was treated with lysine. The outcome of the vaccination failure and shingles were not reported. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. The company considered the vaccination failure to be unrelated to Shingles vaccine. It was unknown if the company considered the shingles to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 23-APR-2025 This case was reported by a patient via interactive digital media. Patient had shingles, patient was vaccinated and still had after-effects. Patient stated that lysine or zosterex that contains lysine in its composition, it makes the virus sleep, helped them a lot. Also reported that when immunity drops, it starts to disturb, that's why they use this medication. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting.; Sender's Comments: Vaccination failure is a listed event which, due to the following criteria (insufficient information provided about the clinical description, details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of disease) is considered unrelated to GSK vaccine Shingles vaccine
More
|
|||||||||
| 2839254 | 05/02/2025 |
VARZOS |
UNKNOWN MANUFACTURER |
UNK |
Herpes zoster
Herpes zoster
|
shingles; This non-serious case was reported by a consumer via interactive digital media and describ...
shingles; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, less than 2 weeks after receiving Shingles vaccine, the patient experienced shingles (Verbatim: shingles). The outcome of the shingles was resolved (duration 1 month). It was unknown if the reporter considered the shingles to be related to Shingles vaccine. It was unknown if the company considered the shingles to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 25-APR-2025 The case was received from the patient via interactive digital media. The reporter reported that the patient got the shingles shot and within two weeks had the shingles for almost a month.
More
|
|||||||||
| 2839255 | 05/02/2025 |
VARZOS |
UNKNOWN MANUFACTURER |
UNK |
Ophthalmic herpes zoster, Vaccination failure
Ophthalmic herpes zoster, Vaccination failure
|
Suspected vaccination failure; ended up with shingles in my eye; This serious case was reported by a...
Suspected vaccination failure; ended up with shingles in my eye; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, 1 month after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and ophthalmic herpes zoster (Verbatim: ended up with shingles in my eye) (serious criteria GSK medically significant). The outcome of the vaccination failure and ophthalmic herpes zoster were not reported. It was unknown if the reporter considered the vaccination failure and ophthalmic herpes zoster to be related to Shingles vaccine. The company considered the vaccination failure and ophthalmic herpes zoster to be unrelated to Shingles vaccine. Additional Information: GSK Receipt Date : 26-APR-2025 This case was reported by a patient via interactive digital media. The patient received the shingles shot and a month later ended up with shingles in his/her eye. The patient stated that never again. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule and laboratory confirmation regarding shingles were unknown at the time of reporting.; Sender's Comments: Vaccination failure is a listed event which, due to the following criteria (insufficient information provided about the clinical description, details regarding the completion of primary vaccination schedule and laboratory confirmation of disease) is considered unrelated to GSK vaccine Shingles vaccine Ophthalmic herpes zoster is an unlisted event which is considered unrelated to GSK vaccine Shingles vaccine
More
|
|||||||||
| 2839256 | 05/02/2025 |
VARZOS |
UNKNOWN MANUFACTURER |
UNK |
Malaise, Pain in extremity
Malaise, Pain in extremity
|
I was sick; arm felt like it was broken it hurt so bad; This non-serious case was reported by a cons...
I was sick; arm felt like it was broken it hurt so bad; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced sickness (Verbatim: I was sick) and pain in arm (Verbatim: arm felt like it was broken it hurt so bad). The outcome of the sickness was resolved and the outcome of the pain in arm was not reported. It was unknown if the reporter considered the sickness and pain in arm to be related to Shingles vaccine. It was unknown if the company considered the sickness and pain in arm to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 25-APR-2025 The case was received from the patient via interactive digital media. The reporter got the vaccine on the second dose he/she was sick for over a week and his/her arm felt like it was broken it hurt so bad. But the reporter was still glad he/she got it because of all the bad stories of the shingles.
More
|
|||||||||
| 2839257 | 05/02/2025 |
VARZOS |
UNKNOWN MANUFACTURER |
UNK |
Herpes zoster, Pain, Vaccination failure
Herpes zoster, Pain, Vaccination failure
|
Suspected Vaccination failure; Shingles; This serious case was reported by a consumer via interactiv...
Suspected Vaccination failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected Vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). The outcome of the vaccination failure and shingles were not reported. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. The company considered the vaccination failure to be unrelated to Shingles vaccine. It was unknown if the company considered the shingles to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 27-APR-2025 This case was reported by a patient via interactive digital media. The patient took this shot and still got it. It was not as bad as others but wished had not taken it. Patient mom had and it was reason to get the shot. The patient remembered her painful time. They did not know what it was till she went to doctor. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting.; Sender's Comments: Vaccination failure is a listed event which, due to the following criteria (insufficient information provided about the clinical description, details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of disease) is considered unrelated to GSK Shingles vaccine.
More
|
|||||||||
| 2839258 | 05/02/2025 |
VARZOS |
UNKNOWN MANUFACTURER |
UNK |
Herpes zoster, Vaccination failure
Herpes zoster, Vaccination failure
|
Suspected vaccination failure; gotten shingles was after they got the vaccine; This serious case was...
Suspected vaccination failure; gotten shingles was after they got the vaccine; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: gotten shingles was after they got the vaccine). The outcome of the vaccination failure and shingles were not reported. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. The company considered the vaccination failure to be unrelated to Shingles vaccine. It was unknown if the company considered the shingles to be related to Shingles vaccine. Additional Information: GSK Receipt Date:27-APR-2025 This case was reported by a patient via interactive digital media. Consumer reported that ironically the only people he/she know that had gotten shingles was after they got the vaccine. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.; Sender's Comments: Vaccination failure is a listed event which, due to the following criteria (insufficient information provided about the clinical description, details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of disease) is considered unrelated to GSK Shingles vaccine.
More
|
|||||||||
| 2839259 | 05/02/2025 |
VARZOS |
UNKNOWN MANUFACTURER |
UNK |
Herpes zoster, Vaccination failure
Herpes zoster, Vaccination failure
|
Suspected vaccination failure; everyone that comes to him with shingles has had the shot; This serio...
Suspected vaccination failure; everyone that comes to him with shingles has had the shot; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in an unspecified number of patients who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: everyone that comes to him with shingles has had the shot). The outcome of the vaccination failure and shingles were not reported. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. The company considered the vaccination failure to be unrelated to Shingles vaccine. It was unknown if the company considered the shingles to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 27-APR-2025 This case was reported by a reporter via interactive digital media. Reporter's physician told him/her that everyone that comes to him with shingles has had the shot, and it does nothing but made big pharma richer. He also told reporter not to waste time and put that in his/her body, it was no good. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting.; Sender's Comments: Vaccination failure is a listed event which, due to the following criteria (insufficient information provided about the clinical description, details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of disease) is considered unrelated to GSK vaccine Shingles vaccine
More
|
|||||||||
| 2839260 | 05/02/2025 |
VARZOS |
UNKNOWN MANUFACTURER |
UNK |
Herpes zoster, Pain, Vaccination failure
Herpes zoster, Pain, Vaccination failure
|
Suspected vaccination failure; took 3 visits to get diagnosed; This serious case was reported by a c...
Suspected vaccination failure; took 3 visits to get diagnosed; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: took 3 visits to get diagnosed). The outcome of the vaccination failure and shingles were not reported. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. The company considered the vaccination failure to be unrelated to Shingles vaccine. It was unknown if the company considered the shingles to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 27-APR-2025 This case was reported by a patient via interactive digital media. The patient had the shots too and it took 3 visits to get diagnosed, emergency room, urgent care and family physician 10 out of 10 on the pain chart. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.; Sender's Comments: Vaccination failure is a listed event which, due to the following criteria ((insufficient information provided about completion of primary vaccination schedule, time to onset and laboratory confirmation regarding shingles) is considered unrelated to GSK vaccine Shingles vaccine.
More
|
|||||||||
| 2839261 | 05/02/2025 |
VARZOS |
UNKNOWN MANUFACTURER |
UNK |
Herpes zoster, Vaccination failure
Herpes zoster, Vaccination failure
|
Suspeceted vaccination failure; Shingels; This serious case was reported by a consumer via interacti...
Suspeceted vaccination failure; Shingels; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspeceted vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingels). The outcome of the vaccination failure and shingles were not reported. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine. The company considered the vaccination failure to be unrelated to Shingles vaccine. It was unknown if the company considered the shingles to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 25-APR-2025 This case was reported by a patient via interactive digital media. The reporter reported that you could get shingles even with the vaccine.; Sender's Comments: Vaccination failure is a listed event which, due to the following criteria (insufficient information provided about the clinical description, details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of disease) is considered unrelated to GSK Shingles vaccine.
More
|
|||||||||
| 2839262 | 05/02/2025 |
VARZOS |
UNKNOWN MANUFACTURER |
UNK |
Incomplete course of vaccination
Incomplete course of vaccination
|
got the first shot over a year, ago but never got the second; This non-serious case was reported by ...
got the first shot over a year, ago but never got the second; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Previously administered products included Shingles vaccine (Received the first shot over a year). On an unknown date, the patient did not receive the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced incomplete course of vaccination (Verbatim: got the first shot over a year, ago but never got the second). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK receipt date: 26-APR-2025 This case was reported by a patient via interactive digital media. The patient got the first shot over a year ago but never got the second, so do the patient need to start all over? Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.
More
|
|||||||||
| 2839263 | 05/02/2025 |
VARZOS |
UNKNOWN MANUFACTURER |
UNK |
Malaise
Malaise
|
I got sick; This non-serious case was reported by a consumer via interactive digital media and descr...
I got sick; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Previously administered products included Shingles vaccine (received 1st dose on an unknown date). On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced sickness (Verbatim: I got sick). The outcome of the sickness was not reported. It was unknown if the reporter considered the sickness to be related to Shingles vaccine. It was unknown if the company considered the sickness to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 28-APR-2025 This case was reported by a patient via interactive digital media. The patient reported that he/she got sick with the second dose. Th patient stated it was first time they ever had a reaction to a vaccine. But they figured way better than getting shingles.
More
|
|||||||||
| 2839264 | 05/02/2025 |
RVX |
UNKNOWN MANUFACTURER |
UNK |
Respiratory syncytial virus infection, Vaccination failure
Respiratory syncytial virus infection, Vaccination failure
|
Suspected vaccination failure; rsv three weeks later; This serious case was reported by a consumer v...
Suspected vaccination failure; rsv three weeks later; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis. On an unknown date, the patient received RSV vaccine. On an unknown date, 3 weeks after receiving RSV vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and respiratory syncytial virus infection (Verbatim: rsv three weeks later). The outcome of the vaccination failure and respiratory syncytial virus infection were not reported. It was unknown if the reporter considered the vaccination failure and respiratory syncytial virus infection to be related to RSV vaccine. The company considered the vaccination failure to be unrelated to RSV vaccine. It was unknown if the company considered the respiratory syncytial virus infection to be related to RSV vaccine. Additional Information: GSK receipt date: 26-APR-2025 This case was reported by a patient via interactive digital media. Patient stated that took the rsv shot and came down with rsv (respiratory syncytial virus infection) three weeks later. This case was considered as suspected vaccination failure as laboratory confirmation regarding respiratory syncytial virus infection were unknown at the time of reporting.; Sender's Comments: Vaccination failure is a listed event which, due to the following criteria (insufficient information provided about the clinical description, details regarding the completion of primary vaccination schedule and laboratory confirmation of disease) is considered unrelated to GSK vaccine RSV vaccine
More
|
|||||||||
| 2839265 | 19 | M | FL | 05/02/2025 |
MMR |
GLAXOSMITHKLINE BIOLOGICALS |
4N222 |
Incorrect route of product administration
Incorrect route of product administration
|
Intramuscular administration of Priorix; This non-serious case was reported by a nurse via call cent...
Intramuscular administration of Priorix; This non-serious case was reported by a nurse via call center representative and described the occurrence of subcutaneous injection formulation administered by other route in a 19-year-old male patient who received MMR (Priorix) (batch number 4N222, expiry date 13-SEP-2026) for prophylaxis. On 28-APR-2025, the patient received Priorix (intramuscular). On 28-APR-2025, an unknown time after receiving Priorix, the patient experienced subcutaneous injection formulation administered by other route (Verbatim: Intramuscular administration of Priorix). The outcome of the subcutaneous injection formulation administered by other route was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 28-APR-2025 The nurse practitioner gave patient the MMR vaccine, the Priorix, the only thing was it was given intramuscularly instead of subcutaneously which led to subcutaneous injection formulation administration by other route. The Vaccine Administration Facility was the same as Primary Reporter. The healthcare professional mentioned that the birth gender of the patient was male, but the legal gender was female.
More
|
||||||
| 2839266 | 11 | M | NM | 05/02/2025 |
MNQ TDAP |
NOVARTIS VACCINES AND DIAGNOSTICS GLAXOSMITHKLINE BIOLOGICALS |
XL223 PJ3RP |
Product storage error; Product storage error
Product storage error; Product storage error
|
Administration after temp. excursion; This non-serious case was reported by a other health professio...
Administration after temp. excursion; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a 11-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number XL223) for prophylaxis. Co-suspect products included DTPa (Reduced antigen) (Boostrix) (batch number PJ3RP) for prophylaxis. On 22-APR-2025, the patient received Menveo and Boostrix. On an unknown date, an unknown time after receiving Menveo and Boostrix, the patient experienced incorrect storage of drug (Verbatim: Administration after temp. excursion). The outcome of the incorrect storage of drug was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 29-APR-2025 The reporter called to report a temperature excursion then healthcare professional asked that between the time that the excursion happened until one day before the reporting date, there was 8 vaccines administered, and that's completely fine, correct. The vaccine administration facility was the same as primary reporter. The reporter mentioned that after the temperature excursion, they administered 8 vaccines. This patient received Boostrix and Menveo (1 vial) after temperature excursion, which led to incorrect storage of drug.
More
|
||||||
| 2839267 | 63 | M | MN | 05/02/2025 |
MMR |
GLAXOSMITHKLINE BIOLOGICALS |
82B72 |
Incorrect route of product administration
Incorrect route of product administration
|
A 63 years old male patient received Priorix IM instead of subcutaneous; This non-serious case was r...
A 63 years old male patient received Priorix IM instead of subcutaneous; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of subcutaneous injection formulation administered by other route in a 63-year-old male patient who received MMR (Priorix) (batch number 82B72, expiry date 13-SEP-2026) for prophylaxis. On an unknown date, the patient received Priorix (intramuscular). On an unknown date, an unknown time after receiving Priorix, the patient experienced subcutaneous injection formulation administered by other route (Verbatim: A 63 years old male patient received Priorix IM instead of subcutaneous). The outcome of the subcutaneous injection formulation administered by other route was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 29-APR-2025 On 29th April 2025, a pharmacist had called to report that a 63 year old male patient had received Priorix intramuscularly instead of subcutaneously, which led to Subcutaneous injection formulation administered by other route. The pharmacist had stated that it had probably not reached the muscle completely because she had used a 5/8 inch needle.
More
|
||||||
| 2839268 | 17 | F | PA | 05/02/2025 |
HEP HEP |
DYNAVAX TECHNOLOGIES CORPORATION GLAXOSMITHKLINE BIOLOGICALS |
F5L5E |
Expired product administered, Interchange of vaccine products; Expired product a...
Expired product administered, Interchange of vaccine products; Expired product administered, Interchange of vaccine products
More
|
EXPIRED DOSE ADMINISTERED; INTERCHANGE OF VACCINES.; This non-serious case was reported by a physici...
EXPIRED DOSE ADMINISTERED; INTERCHANGE OF VACCINES.; This non-serious case was reported by a physician via call center representative and described the occurrence of expired drug administered in a 17-year-old female patient who received HBV (Engerix B) (batch number F5L5E, expiry date 11-APR-2025) for prophylaxis. Co-suspect products included Hepatitis b vaccine rHBsAg (yeast) (Heplisav b) for prophylaxis. On 21-APR-2025, the patient received the 1st dose of Engerix B. In MAR-2025, the patient received Heplisav b. On 21-APR-2025, an unknown time after receiving Engerix B, the patient experienced expired drug administered (Verbatim: EXPIRED DOSE ADMINISTERED) and interchange of vaccine products (Verbatim: INTERCHANGE OF VACCINES.). The outcome of the expired drug administered and interchange of vaccine products were not applicable. Additional Information: GSK Receipt Date: 30-APR-2025 The physician reported that a patient received Engerix on April 21st and unfortunately we found out later that the vaccine had expired on April 11th, which led to expired vaccine used. The reporter was ask what are the adverse effects on that also ask unfortunately received as well heplisav a month prior and we found out after that the Heplisav is not approved for her age range, which led to interchange of vaccine products. The reporter was ask if they should expect any adverse effects for administering an expired Engerix and if there is like additional adverse effects to be expected for her receiving Heplisav a month before that.
More
|
||||||
| 2839269 | M | 05/02/2025 |
COVID19 |
UNKNOWN MANUFACTURER |
|
COVID-19, Vaccination failure
COVID-19, Vaccination failure
|
Diagnosed with covid; Diagnosed with covid; This is a spontaneous report received from a Consumer or...
Diagnosed with covid; Diagnosed with covid; This is a spontaneous report received from a Consumer or other non HCP from medical information team, Program ID: . A 77-year-old male patient received BNT162b2 omicron (kp.2) (COVID-19 VACCINE OMICRON KP.2-MANUFACTURER UNKNOWN), on 17Apr2025 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Apr2025, outcome "unknown" and all described as "Diagnosed with covid". The event "diagnosed with covid" required emergency room visit. Clinical course: Caller stated that he was diagnosed with covid on Saturday (26Apr2025) at the ER and was taken to the hospital by an ambulance. He didn't know when the symptoms started. He had a vaccine for covid on 17Apr2025. He didn't have any symptoms for a few days. He was told Paxlovid works if you take the medicine within so many days of your first symptoms. First symptom could have been maybe within 5 or 6 days afterwards when it was the 17th and today (28Apr2025) the 11th day after he had the vaccine. And maybe 6 or 7 days after he first noticed the symptoms. He doesn't know if Paxlovid would still be of benefit for him or not because there are some guidelines you need to take it within so many days of first having symptoms of Covid. He added that ha hasn't taken Paxlovid. If it's over 5 days it's not beneficial reporter asked. He was prescribed last Saturday and the pharmacy was closed on Sunday and they called him this Morning. He have not started taking the medicine yet. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.
More
|
||||||||
| 2839270 | 63 | M | CA | 05/02/2025 |
COVID19 RSV |
PFIZER\BIONTECH PFIZER\WYETH |
|
Back disorder, Gait inability, Illness, Muscle spasms, Pain in extremity; Back d...
Back disorder, Gait inability, Illness, Muscle spasms, Pain in extremity; Back disorder, Gait inability, Illness, Muscle spasms, Pain in extremity
More
|
can hardly walk/not been able to walk anymore; has pain in his legs; it has a lot of connection with...
can hardly walk/not been able to walk anymore; has pain in his legs; it has a lot of connection with leg cramp and spasm; Patient also took some "Licodine" for back and legs, but it did not work after he got sick; Patient also took some "Licodine" for back and legs, but it did not work after he got sick; This is a spontaneous report received from a Consumer or other non HCP from medical information team. A 63-year-old male patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), on 02Jan2025 as dose 1, single (Batch/Lot number: unknown) at the age of 63 years, in left arm for covid-19 immunisation; rsv vaccine prot.subunit pref 2v (ABRYSVO), on 02Jan2025 as dose number unknown, single (Batch/Lot number: unknown) at the age of 63 years, in left arm for immunisation. The patient's relevant medical history included: "Seizures" (ongoing). Concomitant medication(s) included: LEVETIRACETAM taken for seizure (ongoing). Vaccination history included: Covid-19 vaccine (Dose 1; unknown manufacturer), for COVID-19 immunization; Covid-19 vaccine (Dose 2; unknown manufacturer), for COVID-19 immunization; Covid-19 vaccine (Dose 3; unknown manufacturer), for COVID-19 immunization. The following information was reported: GAIT INABILITY (medically significant), outcome "not recovered", described as "can hardly walk/not been able to walk anymore"; PAIN IN EXTREMITY (non-serious), outcome "not recovered", described as "has pain in his legs"; MUSCLE SPASMS (non-serious), outcome "not recovered", described as "it has a lot of connection with leg cramp and spasm"; BACK DISORDER (non-serious), ILLNESS (non-serious), outcome "unknown" and all described as "Patient also took some "Licodine" for back and legs, but it did not work after he got sick". The events "can hardly walk/not been able to walk anymore", "has pain in his legs", "it has a lot of connection with leg cramp and spasm" and "patient also took some "licodine" for back and legs, but it did not work after he got sick" required physician office visit. Therapeutic measures were taken as a result of gait inability, pain in extremity, muscle spasms, back disorder, illness. Clinical course: Patient called after he was administered the RSV flu shot and Pfizer's covid-19 vaccine concomitantly. He went to the pharmacy, and they told him that it was safe to receive both vaccines at the same time. He mentioned that he received the vaccines at the same time, the same arm in the same minute. Additionally, he said that he went online to report it at the (withheld) website. This would be the fourth time getting the shot of Covid but after the last administration he's not been able to walk anymore, before he used to walk 16-18 miles a day. Wants to know if this is a known AE, because it's not normal. He's already went to his PCP, Neurologist and told him that he's fine. Additionally, he was prescribed medications which made his problem worse. Mentioned that from his work he was obliged to get the vaccines. Patient can hardly walk, has pain in his legs, it has a lot of connection with leg cramp and spasm and in an unnecessary painful situation. Other treatment included Voltaren which did not do any good. Patient also took some "Licodine" for back and legs, but it did not work after he got sick. The patient further stated, "Yes, of course, I need to walk. It is impossible for a healthy man which is the suggested by my neurologist and my doctor, my everything. I got like 4 different doctors even my psychologist said nothing wrong with you. Then, overnight my life changed because of this shot, it got to be something wrong and as far as I read, it has a lot of connection with leg cramp and spasm." The information on the batch/lot number for BNT162b2 omicron (kp.2), rsv vaccine prot.subunit pref 2v will be requested and submitted if and when received.
More
|
||||||
| 2839271 | 73 | F | NC | 05/02/2025 |
COVID19 |
PFIZER\BIONTECH |
|
Hypersensitivity, Rash erythematous, Rash pruritic
Hypersensitivity, Rash erythematous, Rash pruritic
|
a very bright red rash all over face and down both arms/rash was very red and itchy; a very bright r...
a very bright red rash all over face and down both arms/rash was very red and itchy; a very bright red rash all over face and down both arms/rash was very red and itchy; allergic reaction to the Pfizer Covid 19 vaccine; This is a spontaneous report received from a Consumer or other non HCP from medical information team. A 73-year-old female patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), on 04Apr2025 as dose 1, single (Batch/Lot number: unknown) at the age of 73 years, in left lower forearm for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: QSYMIA oral taken for weight decreased, start date: Sep2024 (ongoing); OMEPRAZOLE oral taken for dyspepsia (ongoing); MULTIVITAMIN [ASCORBIC ACID;BIOTIN;CALCIUM PANTOTHENATE;CYANOCOBALAMIN;FOLIC ACID;NICOTINIC ACID;PYRIDOXINE HYDROCHLORIDE;RIBOFLAVIN;THIAMINE HYDROCHLORIDE;TOCOPHERYL ACETATE] oral taken for prophylaxis (ongoing); CITRACAL [CALCIUM CITRATE] oral taken for bone disorder (ongoing). Vaccination history included: BNT162b2 (DOSE 1, SINGLE, Lot: EL5262), administration date: 23Jan2021, for Covid-19 immunization; BNT162b2 (DOSE 2, SINGLE, Lot: EN6201), administration date: 13Feb2021, for Covid-19 immunization; BNT162b2, BNT162b2 omi ba.4-5 (DOSE 3 (BOOSTER), SINGLE, Lot: Has two numbers, FM0698, WAG12853), administration date: 28Mar2022, for Covid-19 immunization; Bnt162b2 nos (DOSE 4 (BOOSTER), SINGLE), administration date: 2023, for Covid-19 immunization; Bnt162b2 nos (DOSE 5 (BOOSTER), SINGLE), administration date: 2023, for Covid-19 immunization; Moderna covid-19 vaccine (DOSE 6 (BOOSTER), SINGLE), administration date: Mar2024, for Covid-19 immunization. The following information was reported: RASH PRURITIC (non-serious), RASH ERYTHEMATOUS (non-serious) all with onset 05Apr2025, outcome "recovered" (Apr2025) and all described as "a very bright red rash all over face and down both arms/rash was very red and itchy"; HYPERSENSITIVITY (non-serious) with onset 05Apr2025, outcome "recovered" (Apr2025), described as "allergic reaction to the Pfizer Covid 19 vaccine". Therapeutic measures were taken as a result of rash pruritic, rash erythematous, hypersensitivity. Additional information: patient had allergic reaction to it, had Pfizer Comirnaty on 04Apr2025. Clarified the reaction patient had been a very bright red rash all over face and down both arms. This was the first one patient ever had an allergic reaction to for the COVID shots. Patient always had Pfizer COVID shots except on one occasion when patient had Moderna COVID shot. Went to the doctor on 06Apr2025 since it was a weekend and was given prednisone and Benadryl. Rash didn't show up until the next day, 05Apr2025, and the rash didn't go away until the last day of the medications, which was about 10 days later. Patient with a question, didn't know if had any advice regarding whether or not patient should take another COVID shot or not take another Pfizer COVID shot or anything like that. patient can't think of more details. patient worked in a health office, clarified patient was not an HCP, the caller was an administrator. Bright red rash all over face and down both arms: Rash didn't show up until the next day, 05Apr2025, and the rash didn't go away until the last day of the medications, which was about 10 days later. Stop date, outcome: Confirmed rash is not ongoing, recovered completely. Concomitant products: Just regular medications, patients then provided information in formal fields from pill box. Patient and patient's husband couldn't think of the name of the multivitamin patient takes; patient then clarified it is Centrum multivitamin. The information on the batch/lot number for BNT162b2 omicron (kp.2) will be requested and submitted if and when received.
More
|
||||||
| 2839272 | F | 05/02/2025 |
COVID19 |
PFIZER\BIONTECH |
|
Dyspnoea
Dyspnoea
|
breathes heavy ever since; This is a spontaneous report received from a Consumer or other non HCP, P...
breathes heavy ever since; This is a spontaneous report received from a Consumer or other non HCP, Program ID: . A female patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DYSPNOEA (non-serious), outcome "unknown", described as "breathes heavy ever since". Additional information: The reporter stated, "I had blood clots right away years ago but my mom also took the shot she breathes heavy ever since". The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received.
More
|
||||||||
| 2839274 | 0.92 | M | NY | 05/02/2025 |
DTPPVHBHPB DTPPVHBHPB PNC20 PNC20 |
MSP VACCINE COMPANY MSP VACCINE COMPANY PFIZER\WYETH PFIZER\WYETH |
U7899AA U7899AA LC5484 LC5484 |
Malaise, Oral disorder, Peripheral swelling, Poor feeding infant, Purpura; Rash,...
Malaise, Oral disorder, Peripheral swelling, Poor feeding infant, Purpura; Rash, Rhinorrhoea, Skin lesion; Malaise, Oral disorder, Peripheral swelling, Poor feeding infant, Purpura; Rash, Rhinorrhoea, Skin lesion
More
|
severe purpuric rash of the face and extremities, swelling of the hands, feet and oral lesions assoc...
severe purpuric rash of the face and extremities, swelling of the hands, feet and oral lesions associated with malaise, cough, rhinorrhea and poor oral intakewhich began within 24 hours of the vaccines and progressed over the course of a week and the remnants of which are still present 2 1/2 mo later. Was admitted to the hospital and given supportive care and IV antibiotics for an infectious complication of the rash.
More
|
||||||
| 2839275 | 5 | F | NH | 05/02/2025 |
DTAPIPV |
GLAXOSMITHKLINE BIOLOGICALS |
|
Bone pain, Product administered at inappropriate site
Bone pain, Product administered at inappropriate site
|
My daughter had her vaccine yesterday and complained that her bone hurt a few hours later in her lef...
My daughter had her vaccine yesterday and complained that her bone hurt a few hours later in her left arm. As a medical assistant myself, I looked at where the injection site was, and it was too close to the shoulder. The placement was too high and too close to shoulder. Patient woke up this morning with the pain being worse than the day before.
More
|
||||||
| 2839276 | 0.17 | F | MA | 05/02/2025 |
DTPPVHBHPB PNC20 RV1 |
MSP VACCINE COMPANY PFIZER\WYETH GLAXOSMITHKLINE BIOLOGICALS |
|
Pyrexia; Pyrexia; Pyrexia
Pyrexia; Pyrexia; Pyrexia
|
Fever of 101F
Fever of 101F
|
||||||
| 2839277 | 31 | M | MA | 05/02/2025 |
ANTH |
EMERGENT BIOSOLUTIONS |
300216A |
Injection site pain
Injection site pain
|
Severe L deltoid pain around the injection site with limited ROM w/ abduction, trx includes NSAIDS, ...
Severe L deltoid pain around the injection site with limited ROM w/ abduction, trx includes NSAIDS, activit mod and ice
More
|
||||||
| 2839278 | 39 | F | MA | 05/02/2025 |
HPV9 HPV9 |
MERCK & CO. INC. MERCK & CO. INC. |
Y012921 Y012921 |
Chills, Dizziness, Headache, Influenza like illness, Nausea; Pyrexia
Chills, Dizziness, Headache, Influenza like illness, Nausea; Pyrexia
|
about 3 hours after injection was received, pt complained of significant flu-like symptoms (fever of...
about 3 hours after injection was received, pt complained of significant flu-like symptoms (fever of 101, chills, nausea and lightheadedness. Also complained of headache. Pt was referred to PCP for evaluation for flu and COVID testing
More
|
||||||
| 2839279 | 86 | F | NH | 05/02/2025 |
COVID19 |
PFIZER\BIONTECH |
|
Cough, Pain in extremity, SARS-CoV-2 test negative
Cough, Pain in extremity, SARS-CoV-2 test negative
|
c/o arm pain the day after injection. Day three developed cough requiring treatment.
c/o arm pain the day after injection. Day three developed cough requiring treatment.
|
||||||
| 2839280 | 88 | F | NH | 05/02/2025 |
COVID19 |
PFIZER\BIONTECH |
|
Chest X-ray normal, Cough, Influenza virus test negative, SARS-CoV-2 test negati...
Chest X-ray normal, Cough, Influenza virus test negative, SARS-CoV-2 test negative, Wheezing
More
|
developed wheezing 4/27 with subsequent onset of cough requiring treatment with steroids and antibio...
developed wheezing 4/27 with subsequent onset of cough requiring treatment with steroids and antibiotics.
More
|
||||||
| 2839281 | 17 | F | WV | 05/02/2025 |
MNQ |
NOVARTIS VACCINES AND DIAGNOSTICS |
Z92L4 |
Dizziness
Dizziness
|
Patients reaction was light headed and dizzy.
Patients reaction was light headed and dizzy.
|
||||||
| 2839282 | 90 | F | NH | 05/02/2025 |
COVID19 COVID19 |
PFIZER\BIONTECH PFIZER\BIONTECH |
|
Chest X-ray abnormal, Cough, Hypervolaemia, Influenza virus test negative, Oxyge...
Chest X-ray abnormal, Cough, Hypervolaemia, Influenza virus test negative, Oxygen saturation decreased; Respiratory syncytial virus test negative, Respiratory tract congestion, SARS-CoV-2 test negative, Vomiting
More
|
onset of cough and congestion 4/28 with decreased oxygen levels and vomiting
onset of cough and congestion 4/28 with decreased oxygen levels and vomiting
|
โ | |||||
| 2839283 | 62 | M | CT | 05/02/2025 |
COVID19 |
PFIZER\BIONTECH |
LP1776 |
No adverse event
No adverse event
|
NO ADVERSE EVENT HAPPENED TO THE PATIENT
NO ADVERSE EVENT HAPPENED TO THE PATIENT
|
||||||
| 2839284 | 59 | F | ND | 05/02/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
mg5s9 |
Back pain, Injection site erythema, Injection site reaction, Paraesthesia, Skin ...
Back pain, Injection site erythema, Injection site reaction, Paraesthesia, Skin exfoliation
More
|
Tingling to right hand, upper back pain that started "pretty quickly after the shot." Flak...
Tingling to right hand, upper back pain that started "pretty quickly after the shot." Flaking of skin at injection site and redness at injection site in addition to tingling of right hand and arm and back pain on right upper back.
More
|
||||||
| 2839285 | 62 | F | TX | 05/02/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
33FD3 |
Pain in extremity, Peripheral swelling
Pain in extremity, Peripheral swelling
|
arm soreness and swelling
arm soreness and swelling
|
||||||
| 2839286 | 17 | M | IN | 05/02/2025 |
MENB MNQ |
NOVARTIS VACCINES AND DIAGNOSTICS NOVARTIS VACCINES AND DIAGNOSTICS |
DD72H 9M2R7 |
Fall, Head injury, Loss of consciousness; Fall, Head injury, Loss of consciousne...
Fall, Head injury, Loss of consciousness; Fall, Head injury, Loss of consciousness
More
|
Patient came in today for a well child appointment at 4:20pm. He was also due for two vaccines, men...
Patient came in today for a well child appointment at 4:20pm. He was also due for two vaccines, menveo and bexsero. He had previously gotten the first dose and was scheduled to receive the second dose today. No noted reaction to any vaccine in our office previously. Grandma accompanied him to his appointment today, called mom and got verbal consent for patient to get his vaccines. He was talkative while the MA went in to give him the shots. Afterwards, they went to checkout, patient was talking to the receptionist scheduling his next appointment. Suddenly he said 'I think I have to' then fell down. He hit his bottom first then fell back and hit the back of his head on the floor, grandma was unable to catch him. Our phlebotomist came running thinking the patient had labs done. Dr. and MAs were close and came running. Patient was out for a few minutes then woke up. Dr. did an exam, no bump or bleeding, she didn't find anything abnormal. He was given ice for his head and water to drink. He sat on the floor for another 5 minutes drinking water and talking to staff. Patient said that he felt fine, he was able to get up unassisted, and walked to their vehicle. Patient was advised that the next time he gets vaccines or a blood draw to make sure he stays seated for 10 minutes afterward so that it doesn't happen again. I don't think that it was preventable because it had never happened to him before per his report, but after the fact grandma mentioned that it did happen to patient's father once or twice.
More
|
||||||
| 2839287 | 0.67 | M | IL | 05/02/2025 |
DTAPIPV MMRV |
GLAXOSMITHKLINE BIOLOGICALS MERCK & CO. INC. |
42Y93 Y009106 |
No adverse event; No adverse event
No adverse event; No adverse event
|
No adverse reaction. Administration error. Vaccines for client's sibling inadvertently administ...
No adverse reaction. Administration error. Vaccines for client's sibling inadvertently administered to this client with appointments at the same time and in the same room. Parent informed of error and provided instructions for follow-up care if needed.
More
|
||||||
| 2839288 | 27 | F | FL | 05/02/2025 |
HEP IPV TDAP VARCEL |
DYNAVAX TECHNOLOGIES CORPORATION SANOFI PASTEUR SANOFI PASTEUR MERCK & CO. INC. |
945660 Y1A201M U8115AA Y015558 |
Pallor, Syncope, Unresponsive to stimuli; Pallor, Syncope, Unresponsive to stimu...
Pallor, Syncope, Unresponsive to stimuli; Pallor, Syncope, Unresponsive to stimuli; Pallor, Syncope, Unresponsive to stimuli; Pallor, Syncope, Unresponsive to stimuli
More
|
Patient fainted after vaccine administration. Patient was pale, and requested water prior to event. ...
Patient fainted after vaccine administration. Patient was pale, and requested water prior to event. Patient was non-responsive for 15 seconds. Patient left facility fully recovered within 20 minutes.
More
|
||||||
| 2839289 | 36 | F | IN | 05/02/2025 |
VARCEL |
MERCK & CO. INC. |
Y014511 |
Fatigue, Oropharyngeal pain, Pain, Pruritus, Rash
Fatigue, Oropharyngeal pain, Pain, Pruritus, Rash
|
body aches, itchy skin, sore throat, fatigue, rash. Was given diphenhydramine 50mg injectable, patie...
body aches, itchy skin, sore throat, fatigue, rash. Was given diphenhydramine 50mg injectable, patient was feeling better when leaving clinic.
More
|
||||||
| 2839290 | 73 | F | AR | 05/02/2025 |
COVID19 |
MODERNA |
012A21A |
COVID-19
COVID-19
|
covid infection with hospitalization after vaccination
covid infection with hospitalization after vaccination
|
||||||
| 2839291 | 71 | M | AR | 05/02/2025 |
COVID19 |
MODERNA |
030B21A |
COVID-19
COVID-19
|
covid infection with hospitalization after vaccination
covid infection with hospitalization after vaccination
|
||||||
| 2839292 | 79 | F | MI | 05/02/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
BY4NA |
Product preparation issue
Product preparation issue
|
Vaccine was not reconstituted, RN administered only the diluent. Patient was contacted, no concerns ...
Vaccine was not reconstituted, RN administered only the diluent. Patient was contacted, no concerns at the inj sight. Patient aware of need to readminister vaccine after 1 month then follow continued guidelines for done #2 to finish the series 2-6 months after.
More
|
||||||
| 2839293 | 65 | F | MI | 05/02/2025 |
COVID19 |
PFIZER\BIONTECH |
lr6262 |
Malaise, Viral test positive
Malaise, Viral test positive
|
tested r/t complaints of not feeling well
tested r/t complaints of not feeling well
|
||||||
| 2839294 | 30 | F | MI | 05/02/2025 |
PNC21 |
MERCK & CO. INC. |
Y019158 |
Cellulitis, Erythema, Swelling
Cellulitis, Erythema, Swelling
|
large redness area slightly swollen and patient was seen at ER at local hospital. She was told she...
large redness area slightly swollen and patient was seen at ER at local hospital. She was told she's having cellulitis and being treated with Doxycycline and Ibuprofen. Two days later, she mentioned that the redness spread and was treated at the hospital with IV antibiotics.
More
|
||||||
| 2839295 | 51 | F | PA | 05/02/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
|
Biopsy skin, Pain in extremity, Peripheral swelling, Rash
Biopsy skin, Pain in extremity, Peripheral swelling, Rash
|
My arm swelled up and painful, then I developed rashes on my arms, legs, and stomach. and my right l...
My arm swelled up and painful, then I developed rashes on my arms, legs, and stomach. and my right leg is painful.
More
|
||||||
| 2839296 | 4 | F | CA | 05/02/2025 |
MMRV |
MERCK & CO. INC. |
Y012341 |
Injection site erythema, Injection site induration, Injection site vesicles, Inj...
Injection site erythema, Injection site induration, Injection site vesicles, Injection site warmth
More
|
Below is statement from emergency room report : ...
Below is statement from emergency room report : " Medical Decision Making 4 yo previously healthy fully vaccinated F who presents with 2 days of blisters and erythema, induration, and warmth to left upper extremity following vaccine administration. On exam, she has nearly circumferential erythema of the left upper extremity with area of induration and few blisters, 1 of which has been denuded, the entire area warm to touch. Overall most consistent with cellulitis. -Considered abscess but lack of fluctuance points against. -Considered sepsis/bacteremia but well appearance, lack of fever, normal perfusion and MS point against. -Considered compartment syndrome given near circumferential nature of cellulitis but compartments still soft, nvi. -Considered MRSA but no h/o such and no fhx recurrent boils. -Considered anaphylaxis but isolated rash to distinct area of arm with no other s/s points against. -Considered varicella or measles given recent vaccine administration but distribution and appearance are not consistent with either rash. Labs were considered but not performed given low suspicion for sepsis/bacteremia and no GI sx to suggest electrolyte abnormality, so these were thought to not change clinical management. Imaging (US soft tissue) was considered but not performed given low suspicion for abscess at this time. Reassured family of low concern for reaction or allergy to vaccine contents given localized distribution, no signs of anaphylaxis. Plan: - Given allergy to Keflex, will prescribe clindamycin for 5-day course per IDMP. First Dose given in ED. - Borders of erythema drawn with pen -May give Tylenol or ibuprofen for discomfort or fever -Strict return precautions discussed, including worsening erythema outside the borders of the outline, pain, induration, fever despite antibiotics. Family agreeable with plan, all questions answered"
More
|
||||||
| 2839297 | 55 | F | KS | 05/02/2025 |
VARZOS VARZOS |
GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS |
47n3y 47n3y |
Erythema, Herpes simplex, Inflammation, Malaise, Mobility decreased; Oropharynge...
Erythema, Herpes simplex, Inflammation, Malaise, Mobility decreased; Oropharyngeal pain, Pain in extremity, Peripheral swelling
More
|
After 2 hours arm begin to show signs of redness. Approximately 24 hours had outbreak of HSV2 . Ar...
After 2 hours arm begin to show signs of redness. Approximately 24 hours had outbreak of HSV2 . Arm swollen from shoulder to elbow, inflamed and swore. Difficulty in moving arm in any motion. Also patient says she had sore throat and not very well.
More
|
||||||
| 2839298 | 11 | F | TN | 05/02/2025 |
MENB MNQ |
NOVARTIS VACCINES AND DIAGNOSTICS SANOFI PASTEUR |
2G3S9 U8375AA |
Inappropriate schedule of product administration, Wrong product administered; In...
Inappropriate schedule of product administration, Wrong product administered; Inappropriate schedule of product administration, Wrong product administered
More
|
pt was due for 3 vaccines today, Tdap/HPV and Men A. Pt came in for a WCC with Brother who was also ...
pt was due for 3 vaccines today, Tdap/HPV and Men A. Pt came in for a WCC with Brother who was also due for vaccines. while I was preparing vaccines there was a mistake and Men A was ordered as Menveo instead of the MenQuadfi which confused me. once it was fixed, I made sure Lot # was in for every vaccine, I grabbed both trays in which the vaccines were in and walked into room, I verified DOB and sat Pt down and proceeded to give the 2 vaccines ( MenA/Men B). my mistake was not verifying again with mom the vaccines each pt was getting. I was overwhelmed already that it flew over my head and made the mistake in not verifying first. it is my first time working in this location and I was stressed out in where everything is at that I forgot to verify that one important thing before giving vaccine. after I realized what had happened, I stopped what I was doing and told mom I was going to step out for a min. i informed my coworker on what had happened, and doctor was informed right away too. the doctor then told me to explain to mom that Men B giving early was not going to hurt Pt, in which I apologized and informed pt Mom. Mom was in a rush and wanted to wait on pt getting HPV and Tdap for another day, I apologized and assured pt mom again that giving Men B early was not a problem. Pt mom agreed in understanding and asked if it was ok to checkout now.
More
|
||||||
| 2839299 | 0.17 | M | NY | 05/02/2025 |
DTPPVHBHPB PNC20 RV1 |
MSP VACCINE COMPANY PFIZER\WYETH GLAXOSMITHKLINE BIOLOGICALS |
U7921AA LJ5282 LL455 |
Cyanosis, Lethargy; Cyanosis, Lethargy; Cyanosis, Lethargy
Cyanosis, Lethargy; Cyanosis, Lethargy; Cyanosis, Lethargy
|
15min post vaccination very lethargic, cyanotic
15min post vaccination very lethargic, cyanotic
|
||||||
| 2839300 | 0.58 | M | NY | 05/02/2025 |
COVID19 |
PFIZER\BIONTECH |
|
Decreased appetite, Irritability, Pyrexia, Somnolence
Decreased appetite, Irritability, Pyrexia, Somnolence
|
Fever (highest recorded temp was 102.7 F) lasting at least 72 hours, with irritability, loss of appe...
Fever (highest recorded temp was 102.7 F) lasting at least 72 hours, with irritability, loss of appetite, and sleepiness accompanying. Treating with Motrin and Tylenol.
More
|
||||||
| 2839301 | 0.17 | M | CA | 05/02/2025 |
DTPPVHBHPB PNC20 RV1 |
MSP VACCINE COMPANY PFIZER\WYETH GLAXOSMITHKLINE BIOLOGICALS |
U8265AA MF0415 EX434 |
Infantile vomiting, Underdose; Infantile vomiting, Underdose; Infantile vomiting...
Infantile vomiting, Underdose; Infantile vomiting, Underdose; Infantile vomiting, Underdose
More
|
While giving the oral Rotarix, baby began to spit up a little bit. We stopped administering and clea...
While giving the oral Rotarix, baby began to spit up a little bit. We stopped administering and cleaned spit up and began again. Baby began spit up more than the first time. Medical assistant asked mom if she had fed baby before coming in and she stated no, We then stopped administering completely and notified provider about the adverse reaction. Provider went back into exam room to assess the patient. Pt was doing well and left clinic 15 min later.
More
|
||||||
| 2839302 | 18 | M | 05/02/2025 |
MENB MENB |
PFIZER\WYETH PFIZER\WYETH |
|
Headache, Injection site discomfort, Injection site erythema, Injection site pai...
Headache, Injection site discomfort, Injection site erythema, Injection site pain, Injection site swelling; Loss of personal independence in daily activities
More
|
24 hours after the meningitis B vaccine, my son's arm at the injection site was very red, raise...
24 hours after the meningitis B vaccine, my son's arm at the injection site was very red, raised, and it spread to an area approximately 4" wide x 8" long, and he complained of discomfort and soreness. Then 36-38 hours after he complained of an excruciating headache. The vaccine was Tuesday afternoon, he missed school yesterday and today. He is in bed. And says his head hurts worse when he sits up. Doctor suggested alternating advil and tylenol, which we are doing. And he is icing his head.
More
|